Cargando…

Corticosteroid Treatment Impact on Spinal Deformity in Duchenne Muscular Dystrophy

Duchenne muscular dystrophy is a progressive disease with loss of ambulation at around 9-10 years of age, followed, if untreated, by development of scoliosis, respiratory insufficiency, and death in the second decade of life. This review highlights the natural history of the disease, in particular,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sanzarello, Ilaria, Merlini, Luciano, Traina, Francesco, Rosa, Michele Attilio, Faldini, Cesare
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4897302/ https://www.ncbi.nlm.nih.gov/pubmed/27382620 http://dx.doi.org/10.1155/2014/965235

Ejemplares similares

Quadriceps muscle strength in Duchenne muscular dystrophy and effect of corticosteroid treatment
por: Merlini, Luciano, et al.
Publicado: (2020)

Tendon Extracellular Matrix Alterations in Ullrich Congenital Muscular Dystrophy
por: Sardone, Francesca, et al.
Publicado: (2016)

Improving clinical trial design for Duchenne muscular dystrophy
por: Merlini, Luciano, et al.
Publicado: (2015)

Congenital idiopathic talipes equinovarus before and after walking age: observations and strategy of treatment from a series of 88 cases
por: Faldini, Cesare, et al.
Publicado: (2015)

Early Morphological Changes of the Rectus Femoris Muscle and Deep Fascia in Ullrich Congenital Muscular Dystrophy
por: Sabatelli, Patrizia, et al.
Publicado: (2022)

Spinal Deformity Correction in Duchenne Muscular Dystrophy (DMD): Comparing the Outcome of Two Instrumentation Techniques
por: Debnath, Ujjwal Kanti, et al.
Publicado: (2011)

Variability and trends in corticosteroid use by male United States participants with Duchenne muscular dystrophy in the Duchenne Registry
por: Cowen, Leslie, et al.
Publicado: (2019)

Newborn screening for Duchenne muscular dystrophy‐early detection and diagnostic algorithm for female carriers of Duchenne muscular dystrophy
por: Gruber, Dorota, et al.
Publicado: (2022)

Corticosteroid use and bone health management for Duchenne muscular dystrophy in South Korea
por: Yoon, Jin A, et al.
Publicado: (2022)

Surgical and long-term functional outcomes of patients with Duchenne muscular dystrophy following spinal deformity correction
por: Roberts, Simon, et al.
Publicado: (2023)

Survival in Duchenne muscular dystrophy
por: RALL, SUSANNE, et al.
Publicado: (2012)

Theragnosis for Duchenne Muscular Dystrophy
por: Luce, Leonela, et al.
Publicado: (2021)

How is Physical Activity Measured in Spinal Muscular Atrophy and Duchenne Muscular Dystrophy?
por: Uher, David, et al.
Publicado: (2023)

Melanocytes—A Novel Tool to Study Mitochondrial Dysfunction in Duchenne Muscular Dystrophy
por: Pellegrini, Camilla, et al.
Publicado: (2013)

Body Composition, Muscle Strength, and Physical Function of Patients with Bethlem Myopathy and Ullrich Congenital Muscular Dystrophy
por: Miscione, Maria Teresa, et al.
Publicado: (2013)

Hypokalemia complicating Duchenne muscular dystrophy.
por: McDonald, B., et al.
Publicado: (1987)

The role of fibrosis in Duchenne muscular dystrophy
por: KLINGLER, WERNER, et al.
Publicado: (2012)

Delay in Diagnosis of Duchenne Muscular Dystrophy
por: Rao, Vamshi K., et al.
Publicado: (2015)

Circulating Biomarkers for Duchenne Muscular Dystrophy
por: Aartsma-Rus, Annemieke, et al.
Publicado: (2015)

Targeting angiogenesis in Duchenne muscular dystrophy
por: Podkalicka, Paulina, et al.
Publicado: (2019)

Regenerative biomarkers for Duchenne muscular dystrophy
por: Guiraud, Simon, et al.
Publicado: (2019)

Eteplirsen in the treatment of Duchenne muscular dystrophy
por: Lim, Kenji Rowel Q, et al.
Publicado: (2017)

Nutritional Challenges in Duchenne Muscular Dystrophy
por: Salera, Simona, et al.
Publicado: (2017)

Lifetime Care of Duchenne Muscular Dystrophy
por: MacKintosh, Erin W., et al.
Publicado: (2020)

The Duchenne muscular dystrophy gene and cancer
por: Jones, Leanne, et al.
Publicado: (2020)

CRISPR Therapeutics for Duchenne Muscular Dystrophy
por: Erkut, Esra, et al.
Publicado: (2022)

Exon-Skipping in Duchenne Muscular Dystrophy
por: Takeda, Shin’ichi, et al.
Publicado: (2021)

Gene Therapy for Duchenne Muscular Dystrophy
por: Elangkovan, Nertiyan, et al.
Publicado: (2021)

Family reflections: Duchenne Muscular Dystrophy
por: Gill, Omaira
Publicado: (2022)

Cardiac therapies for Duchenne muscular dystrophy
por: Shah, Md Nur Ahad, et al.
Publicado: (2023)

Perspectives on Everyday Life Challenges of Danish Young People With Duchenne Muscular Dystrophy (DMD) on Corticosteroids
por: Handberg, Charlotte, et al.
Publicado: (2022)

The clinical course of Duchenne muscular dystrophy in the corticosteroid treatment era: a systematic literature review
por: Szabo, Shelagh M., et al.
Publicado: (2021)

Trans‐generational epigenetic regulation associated with the amelioration of Duchenne Muscular Dystrophy
por: Martone, Julie, et al.
Publicado: (2020)

A Roadmap to Newborn Screening for Duchenne Muscular Dystrophy
por: Al-Zaidy, Samiah A., et al.
Publicado: (2017)

Tumor Necrosis Factor Receptor SF10A (TNFRSF10A) SNPs Correlate With Corticosteroid Response in Duchenne Muscular Dystrophy
por: Passarelli, Chiara, et al.
Publicado: (2020)

Hippo signaling pathway is altered in Duchenne muscular dystrophy
por: Vita, Gian Luca, et al.
Publicado: (2018)

Magnetic resonance imaging of the erector spinae muscles in Duchenne muscular dystrophy: implication for scoliotic deformities
por: Zoabli, Gnahoua, et al.
Publicado: (2008)

Quantitative assessment of left ventricular longitudinal function and myocardial deformation in Duchenne muscular dystrophy patients
por: Panovský, Roman, et al.
Publicado: (2021)

Growth pattern trajectories in boys with Duchenne muscular dystrophy
por: Stimpson, Georgia, et al.
Publicado: (2022)

Effect of Yoga and Ayurveda on Duchenne Muscular Dystrophy
por: Telles, Shirley, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_dpmplnlta2tmd0rfdjt1q9tb6u